FeesSafety
Pluang+

Aktis Oncology undervalued despite strong cash and promising drug programs, with key data expected in 2027

Market News
14 Oct 2026, 23:27 WIB
Seeking Alpha
View Source
Bullish
Aktis Oncology undervalued despite strong cash and promising drug programs, with key data expected in 2027

Aktis Oncology is trading below its IPO price despite holding $517.3 million in cash and a $1.2 billion partnership with Eli Lilly, giving it financial stability through 2029. The company is developing two innovative radiopharmaceutical drugs, AKY-1189 and AKY-2519, both with Fast Track status and early positive data reducing development risks. The growing use of Padcev expands the market opportunity for Aktis' treatments, positioning the company for significant growth ahead of key Phase 1b study results expected in the first quarter of 2027.

Aktis Oncology is the subject of this update, with Pluang providing a snapshot of the health sector market. Of 150 priced health-sector US stocks on Pluang, 90 rose and 60 fell today. Notable movers include Liquidia Corporation (LQDA) at USD 33.90 with a 1-day change of +26.45%, MiniMed Group Inc. (MMED) at USD 16.71 with a 1-day change of -9.18%, and Alumis Inc. (ALMS) at USD 6.08 with a 1-day change of -7.39%, as of Oct 15, 2026 03:02 WIB.

More News

All patients in Alpha Tau's glioblastoma trial alive with 100% tumor response and no serious side effects

All patients in Alpha Tau's glioblastoma trial alive with 100% tumor response and no serious side effects

Alpha Tau Medical announced interim results from its U.S. trial of Alpha DaRT therapy for recurrent glioblastoma, showing all eight treated patients are alive with a median follow-up of 6.9 months and no median survival reached. Among six patients as...

Market News
Bullish
3 hours ago
SoFi forecasts 50% earnings growth in 2027 and says no new capital needed.

SoFi forecasts 50% earnings growth in 2027 and says no new capital needed.

SoFi announced it expects about 50% growth in earnings for the year 2027, signaling strong financial performance ahead. The company also stated it will not need to raise new capital, indicating confidence in its current funding and business model. Th...

Company Fundamentals
Bullish
5 hours ago
Aster (ASTER) token surges 18.57% in one hour, up 31.34% over 24 hours on Binance.

Aster (ASTER) token surges 18.57% in one hour, up 31.34% over 24 hours on Binance.

Aster (ASTER) token price jumped 18.57% within one hour to $0.65 on Binance, marking a 31.34% increase over the past 24 hours. The surge was accompanied by significant liquidations, with $280,000 in short positions and $70,000 in long positions liqui...

Market News
Bullish
5 hours ago
Bitcoin dips below $73k amid rising selling and inflation fears, bulls must defend $65k support to sustain rally

Bitcoin dips below $73k amid rising selling and inflation fears, bulls must defend $65k support to sustain rally

US inflation rose 0.4% in October, higher than expected, driven by oil prices and tariffs, prompting Fed rate hike talks. This pressured Bitcoin, which fell below $73k due to increased institutional and retail selling, short-term holder sensitivity, ...

Market News
Bearish
5 hours ago
Group reportedly earned $6M buying Cash Cat and PONS before Robinhood listed them on Robinhood Chain.

Group reportedly earned $6M buying Cash Cat and PONS before Robinhood listed them on Robinhood Chain.

A trader on X (@3i) claims a group made over $6 million by purchasing Cash Cat (CASHCAT) and PONS tokens before Robinhood officially listed them on its Robinhood Chain network. The group anticipated the listings by linking a public code change at Bit...

Market News
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App